CARL ZEISS VISION INC

CARL ZEISS VISION INC specializes in the design, manufacturing, and precision engineering of ophthalmic optical systems and vision correction products, operating within the medical device manufacturing sector. Their core capabilities center on the development of high-precision lenses, progressive multifocal designs, and customized vision solutions for corrective eyewear, leveraging advanced optical metrology, surface grinding, and coating technologies. The company applies rigorous optical design principles and quality control protocols aligned with ISO 13485 standards to ensure clinical performance and patient safety. Key differentiators include proprietary lens optimization algorithms, automated production systems for mass customization, and integration of digital surfacing technologies to meet individual prescription requirements with sub-micron accuracy. Award history is not available to infer specific agency engagements or contract patterns. Consequently, no definitive relationship patterns with federal agencies can be established from the provided data. The primary NAICS code 339115 corresponds to Surgical and Medical Instrument Manufacturing, which in practice encompasses the production of vision correction devices classified as Class I or II medical devices under FDA regulations. The company’s market positioning is focused on the optical health segment, serving optometric and ophthalmic providers through FDA-cleared products that support refractive error correction and visual rehabilitation. CARL ZEISS VISION INC is structured as a limited liability entity (2L) headquartered in Hebron, Kentucky, with no publicly disclosed government certifications. The company operates as a specialized manufacturer within the U.S. medical device supply chain, relying on domestic production capabilities to support commercial and institutional distribution channels. Its government market presence, if any, is not discernible from available award data.